CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

86

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

Tags:

Previous Article

The maternal microbiome during pregnancy impacts offspring’s stem cells in mice

CAR-T cells for multiple sclerosis

Related Posts

JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia

JAK-STAT1 as therapeutic target for EGFR deficiency-ass...

94

Immune aging impairs muscle regeneration via macrophage-derived anti-oxidant selenoprotein P

Immune aging impairs muscle regeneration via macrophage...

70

Mutation in the mitochondrial chaperone TRAP1 leads to autism with more severe symptoms in males

Mutation in the mitochondrial chaperone TRAP1 leads to ...

61